1H25 回顾：大客户游戏与客户端业务迅速增长，带动公司Q2 营收达新高 2Q25 通富微电大客户 AMD 营收持续增长，主因 AMD 最新"Zen 5"架构 的 AMD 锐龙台式处理器及更丰富的产品组合的强劲需求，以及游戏主机定 制芯片和游戏 GPU 需求的增加，带动其客户端业务与游戏业务增长明显， 分别实现 67.5%/73.2%的同比增长与 8.9%/73.1%的环比增长，通富微电作 为 AMD 产品封测的主要供应商，同步受益实现营收同环比增长，稼动率回 升也带动毛利率水平增长。公司已完成对京隆科技 26%股权的收购，京隆 科技在高端集成电路专业测试领域具备差异化竞争优势，有望为公司开拓第 二增长曲线，同时为公司带来投资收益增长。 证券研究报告 通富微电 (002156 CH) AMD 游戏与客户端带动 Q2 营收环增 2025 年 8 月 29 日│中国内地 半导体 通富微电发布半年报，1H25 实现营收 130.38 亿元（yoy+17.67%），归母 净利 4.12 亿元（yoy+27.72%），扣非净利 4.20 亿元（yoy+32.85%）。其 中 Q2 实现营收 69.46 亿元（yoy+1 ...

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 82.50 [1]. Core Insights - The company demonstrated rapid growth in H1 2025, achieving revenue of RMB 3.113 billion, a year-on-year increase of 22.5%, and a net profit of RMB 1.18 billion, up 20.6% year-on-year, with a net profit margin of 37.98% [5]. - The company is focusing on long-term strategies, maintaining stable business operations, and ensuring both revenue and profit growth while keeping profitability relatively stable [5]. - The company is expanding the application boundaries of recombinant collagen through research and development, enhancing brand value, and iterating quality products to create a long-term growth matrix [5][6]. Financial Performance - For H1 2025, the company's revenue from its main brand, Kefu Mei, was RMB 2.542 billion, a year-on-year increase of 22.7% [6]. - The company reported a gross margin of 81.68%, with a sales and distribution expense ratio of 34.01%, reflecting optimization in sales expenses [8]. - The company expects to maintain its profit forecast, projecting net profits of RMB 2.6 billion, RMB 3.203 billion, and RMB 3.812 billion for 2025, 2026, and 2027 respectively, with corresponding EPS of RMB 2.53, RMB 3.11, and RMB 3.71 [9]. Market Position and Growth Potential - The company has successfully expanded its offline channels, entering approximately 1,700 public/private hospitals and clinics, and over 13,000 chain pharmacies [7]. - The direct sales through e-commerce platforms showed significant growth, achieving revenue of RMB 391 million, a year-on-year increase of 133.6% [7]. - The company is also exploring international markets, having entered Watsons in Malaysia, which is expected to provide new growth opportunities [7]. Valuation Metrics - The company is valued at a market capitalization of HKD 55.955 billion, with a closing price of HKD 52.25 as of August 28 [1]. - The projected PE ratios for the upcoming years are 24.23 for 2025, 19.22 for 2026, and 15.60 for 2027, indicating a favorable valuation compared to peers [4][11].

Investment Rating - The report maintains an "Overweight" rating for the company with a target price of 372 RMB [6][4]. Core Insights - The company achieved a revenue of 1.938 billion RMB in 1H25, representing a year-over-year increase of 26.58%, and a net profit of 305 million RMB, up 106.45% year-over-year [1][2]. - In 2Q25, the company experienced a revenue of 944 million RMB, a year-over-year increase of 7.48%, but a quarter-over-quarter decline of 5.09% due to supply chain adjustments leading to a temporary supply shortage [1][2]. - The gross margin returned to over 40% in 2Q25, reaching 40.12%, marking the first time since 3Q22 that it exceeded this threshold [2]. - The company is expanding its market share in traditional segments like headphones and smartwatches while also entering new application areas such as smart glasses and wireless microphones [3][4]. Summary by Sections Financial Performance - 1H25 revenue was 1.938 billion RMB, with a net profit of 305 million RMB, and a significant increase in R&D expenses to 228 million RMB in 2Q25, up 36.37% quarter-over-quarter [1][2]. - The company expects revenue to recover in 3Q25, driven by new applications in wireless microphones and smart glasses [1][3]. Market Position and Strategy - The company is successfully increasing its market share in the headphone and smartwatch markets, with new clients and product launches contributing to growth [3]. - The BES2800 chip is gaining traction in various applications, enhancing the company's revenue potential in emerging markets [2][3]. Profitability and Valuation - The report projects revenue for 2025 to be 4.595 billion RMB, with corresponding net profits of 835.54 million RMB, reflecting a downward adjustment from previous estimates [4][10]. - The target price of 372 RMB corresponds to a 75x PE ratio for 2025, indicating a favorable valuation compared to market expectations [4][6].

Investment Rating - The investment rating for the company is "Buy" with a target price of RMB 13.50 [7][8]. Core Views - The company reported a revenue of RMB 1.061 billion for H1 2025, a year-on-year decrease of 32.78%, and a net profit attributable to shareholders of RMB 102 million, down 32.31% year-on-year. The decline in revenue is attributed to slower construction progress and significant price competition in the pipeline industry [1][2]. - Despite the challenges, the demand for engineering pipelines is expected to improve due to the rapid implementation of major water conservancy projects and urban renewal initiatives [1][4]. - The company has a sufficient order backlog, and as key engineering projects progress in the second half of the year, the order backlog is expected to be released [2]. Summary by Sections Financial Performance - In H1 2025, the company achieved revenue of RMB 1.061 billion, with a Q2 revenue of RMB 539 million, reflecting a year-on-year decline of 42.23% and a quarter-on-quarter increase of 3.37%. The net profit for Q2 was RMB 59.04 million, down 40% year-on-year but up 37.84% quarter-on-quarter [1][2]. - The gross margin for H1 2025 was 20.08%, a slight increase of 0.55 percentage points year-on-year. The gross margins for pipe sales and pipeline engineering installation were 23.4% and 45.0%, respectively [2]. Cost and Cash Flow - The operating expense ratio for H1 2025 was 12.34%, an increase of 2.93 percentage points year-on-year. The company effectively controlled accounts receivable, which decreased by 5.27% compared to the beginning of the year [3]. - The net cash flow from operating activities was RMB 41 million, a year-on-year increase of 125.60%, primarily due to increased cash received from sales of goods and services [3]. Industry Outlook - The company is positioned to benefit from national policies promoting the construction of water and gas pipelines, as well as urban infrastructure upgrades. This presents a significant opportunity for the pipeline industry [4]. - The company plans to leverage its comprehensive pipeline industry chain advantages and adopt a dual sales model to enhance its market position [4]. Profit Forecast and Valuation - The profit forecasts for 2025-2027 have been revised downwards due to ongoing price competition in the short-cycle pipeline industry. The expected net profits for 2025, 2026, and 2027 are RMB 153 million, RMB 177 million, and RMB 224 million, respectively [5][11]. - The company is assigned a PE valuation of 25 times for 2025, leading to an adjusted target price of RMB 13.50, reflecting a favorable outlook based on its strategic positioning and market conditions [5].

Investment Rating - The investment rating for the company is "Buy" with a target price of 155.31 RMB [7][8]. Core Views - The company has shown continuous high revenue growth, achieving 12.867 billion RMB in revenue for the first half of 2025, a year-on-year increase of 33.36%, and a net profit of 1.167 billion RMB, also up 33.80% year-on-year [1][2]. - New product categories such as 3D printers and robotic lawn mowers are expected to drive future revenue growth [1][4]. - The company plans to pursue a listing in Hong Kong to enhance its global expansion strategy and brand image [4]. Summary by Sections Revenue and Profitability - In H1 2025, the company generated revenue of 12.867 billion RMB, with a net profit of 1.167 billion RMB, reflecting a year-on-year growth of 33.36% and 33.80% respectively [1][2]. - The second quarter saw revenue of 6.873 billion RMB, a year-on-year increase of 30.41% and a quarter-on-quarter increase of 14.68% [1]. Product and Channel Performance - Revenue from different product categories in H1 2025 included 6.816 billion RMB from charging and storage, 3.251 billion RMB from smart innovation, and 2.798 billion RMB from smart audio-visual, with year-on-year growth rates of 37%, 38%, and 21% respectively [2]. - Online and offline revenue for H1 2025 was 8.675 billion RMB and 4.192 billion RMB, showing year-on-year increases of 29% and 44% respectively [2]. Research and Development - The company increased its R&D investment, with an R&D expense ratio of 9.28% in H1 2025, up 0.99 percentage points year-on-year [3]. - Investment income from financial products contributed 155 million RMB to the profit, an increase of 117 million RMB year-on-year [3]. Future Outlook and Valuation - The company has adjusted its revenue expectations upward and forecasts net profits for 2025-2027 to be 2.684 billion RMB, 3.028 billion RMB, and 3.552 billion RMB respectively, with corresponding EPS of 5.01, 5.65, and 6.63 RMB [5][11]. - The target price of 155.31 RMB corresponds to a PE ratio of 31 times for 2025 [5][8].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 14.80 [7][8]. Core Views - The company reported a revenue of RMB 1.964 billion for H1 2025, a year-on-year decrease of 12.43%, and a net profit attributable to shareholders of RMB 22.60 million, down 39.69% year-on-year. The second quarter revenue was RMB 983 million, reflecting a year-on-year decline of 11.12% [1][2]. - The overall gross margin for H1 2025 was 14.46%, a decrease of 1.95 percentage points year-on-year, with specific margins for glass, cement, and steel refractory materials at 15.48%, 20.89%, and 11.43%, respectively [2]. - The company has implemented effective cost control measures, achieving a reduction in costs of RMB 25.27 million and an increase in revenue of RMB 28.96 million [4]. Summary by Sections Financial Performance - H1 2025 revenue was RMB 1.964 billion, down 12.43% year-on-year, with a net profit of RMB 22.60 million, down 39.69% year-on-year. Q2 revenue was RMB 983 million, with a net profit of RMB 611.42 million, down 59.38% year-on-year [1][2]. - The company’s gross margin for H1 2025 was 14.46%, down 1.95 percentage points year-on-year, with Q2 gross margin at 13.68% [2]. Cost Management - The company managed to reduce costs by RMB 25.27 million and increase revenue by RMB 28.96 million through various cost control measures [4]. - The operating expense ratio for H1 2025 was 11.16%, a decrease of 1.03 percentage points year-on-year [3]. Future Outlook - The company anticipates improvement in sales as the "anti-involution" measures progress, potentially enhancing the operating quality of downstream industries such as glass, cement, and steel [1][2]. - Profit forecasts for 2025-2027 are set at RMB 92.32 million, RMB 103.98 million, and RMB 113.61 million, respectively, with corresponding EPS of RMB 0.39, RMB 0.44, and RMB 0.48 [5][11].

Investment Rating - The investment rating for the company is maintained at "Buy" with a target price of RMB 35.70 [1][3][11] Core Views - The company has shown stable internal operations with a year-on-year revenue increase of 2.16% in H1 2025, driven by a partial recovery in the industry [7][8] - The company's net profit attributable to the parent company for H1 2025 was RMB 1.21 billion, reflecting a year-on-year growth of 30.48% [7] - The company is leveraging AI technology to enhance operational efficiency, with significant improvements in various publishing processes [10] Financial Performance - H1 2025 total revenue reached RMB 822 million, with a gross margin of 40.73%, up 2.07 percentage points year-on-year [7][8] - The company plans to distribute a mid-year dividend of RMB 1.60 per 10 shares (tax included) [7] - The company's market capitalization is RMB 6,197 million, with a closing price of RMB 32.59 as of August 28, 2025 [3] Market Position - The company holds a leading position in the book retail market, with a market share of 3.06% in H1 2025, ranking first among domestic publishers [9] - The company has achieved significant market share in various categories, including management, biography, art, and popular science books [9] Future Projections - Revenue projections for 2024 to 2027 are expected to grow from RMB 1,687 million in 2024 to RMB 1,896 million in 2027, with a compound annual growth rate of approximately 4.23% [6][11] - The net profit attributable to the parent company is projected to increase from RMB 118.67 million in 2024 to RMB 258.08 million in 2027 [6][11] - The company is expected to maintain a PE ratio of 30X for 2025, reflecting its competitive position and operational efficiency improvements [11]

Investment Rating - The report maintains a "Buy" rating for the company [6][8]. Core Views - The company experienced significant revenue and profit pressure in the first half of 2025, with revenue, net profit attributable to shareholders, and net profit excluding non-recurring items declining by 27%, 40%, and 46% year-on-year, respectively [1][2]. - Despite the current challenges, the company is expected to gradually narrow the revenue decline, with potential growth from its traditional Chinese medicine, biopharmaceuticals, and chemical drugs pipelines [1][2]. - The collaboration with Dong'e Ejiao to promote Huangqi Essence is anticipated to unlock market potential, leveraging Dong'e Ejiao's strong marketing and distribution capabilities [4]. Summary by Sections Financial Performance - In 1H25, the company's revenue was 1.64 billion RMB, with a net profit of 140 million RMB and a net profit excluding non-recurring items of 120 million RMB, reflecting a year-on-year decline of 27%, 40%, and 46%, respectively [1]. - In 2Q25, revenue was 764 million RMB, with a net profit of 59 million RMB and a net profit excluding non-recurring items of 38 million RMB, showing declines of 15%, 42%, and 53% year-on-year [1]. Product Performance - Core products faced sales pressure, with injection revenue down 40% to 510 million RMB and oral liquid revenue down 49% to 280 million RMB in 1H25 [2]. - Other dosage forms showed mixed performance, with capsules and granules experiencing declines of approximately 5% and 18%, while tablets, patches, and gels saw growth of 5% to 12% [2]. Research and Development - The company has a robust R&D pipeline, with two approved traditional Chinese medicines and several in various clinical trial phases [5]. - The acquisition of Zhongxin Pharmaceutical is expected to enhance the company's product offerings, particularly in diabetes treatment with unique dual-target and triple-target products [3]. Valuation and Forecast - The revenue forecast for 2025-2027 has been adjusted downwards by 8%, 11%, and 13%, respectively, with expected net profits of 400 million RMB, 460 million RMB, and 530 million RMB, reflecting year-on-year growth of 2%, 15%, and 15% [6]. - The target price is set at 21.26 RMB, based on a 30x PE for 2025, indicating a premium over the average PE of comparable companies [6].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 82.95 [6][8]. Core Insights - The company's inverter business is experiencing a recovery in demand in Europe and significant growth in emerging markets, demonstrating strong profitability resilience [3][4]. - The commercial storage product shipments have shown impressive year-on-year growth of 213%, with new products over 100kW being launched and gradually ramping up [4][5]. - The company is actively developing in the AIDC field, having established a research team focused on solid-state transformers [5]. Summary by Sections Inverter Business - The completion of inventory reduction in European household storage and the expansion of commercial storage are noted, with favorable policy subsidies in Eastern Europe contributing to a gradual market recovery [4]. - The company has tailored solutions for the Indonesian market, addressing its unique logistical and installation challenges, and anticipates rapid growth in shipments following the July subsidy implementation in Australia [4]. Commercial Storage - In the first half of the year, the company shipped 42,900 commercial storage inverters, marking a year-on-year increase of 213% due to the introduction of dynamic pricing mechanisms in Europe [4]. - The company aims to achieve a monthly shipment of 1,000 units by the end of the year for its new 100kW+ commercial storage inverters [4]. Battery Packs - The company reported battery pack revenue of RMB 1.422 billion in the first half of the year, reflecting an 85.8% year-on-year increase, with expectations for continued growth in Q3 [4]. - The interfaces for battery packs associated with the new 100kW+ commercial storage products are not open to external access, which is expected to drive sales of the company's supporting battery packs [4]. Employee Incentives - An employee stock ownership plan was announced, allowing up to 800 employees to subscribe to 0.21% of the company's shares at RMB 30.19 per share, with performance targets set for 2025 [5]. AIDC Development - The company is leveraging its strong technical expertise in power electronics to enter the AIDC market, with plans to launch products within approximately 18 months [5]. Profit Forecast and Valuation - The company’s projected net profits for 2025-2027 are RMB 35.73 billion, RMB 44.36 billion, and RMB 52.87 billion respectively, maintaining a target PE of 21 times for 2025 [6][11].

Investment Rating - The report maintains an "Accumulate" rating for the company [6][4] Core Views - The company reported a revenue of 4.975 billion RMB in H1 2025, a year-on-year decrease of 1.38%, and a net profit attributable to the parent company of 35.17 million RMB, down 39.52% year-on-year [1][2] - Despite the decline in revenue and profit, the gross margins for slaughtering and food segments improved, driven by cost control measures [2][3] - The company continues to focus on its "one body, two wings" strategy, emphasizing food as the main business supported by slaughtering and breeding, while also paying attention to the growth of the prepared food industry [1][3] Revenue and Profit Analysis - In H1 2025, the slaughtering segment achieved a revenue of 4.073 billion RMB, an increase of 4.41% year-on-year, with a gross margin improvement of 0.71 percentage points [2][3] - The food segment reported a revenue of 866 million RMB, a decrease of 19.91% year-on-year, with a gross margin of 13.72%, up 1.14 percentage points [2][3] - Online sales of prepared dishes increased by 44.98% year-on-year, indicating strong growth in this channel [3] Financial Forecast and Valuation - The company is projected to achieve net profits of 146 million RMB, 212 million RMB, and 265 million RMB for the years 2025, 2026, and 2027, respectively, with corresponding EPS of 0.13, 0.20, and 0.25 RMB [4][9] - The target price is set at 6.34 RMB, based on a valuation of 49 times the expected earnings for 2025 [4][7]